Evaluating the educational content of direct-to-consumer fulfillment materials

American Journal of Health-System Pharmacy

Volumn 62, Issue 6, 2005, Pages 620-625

  Chao, Blenda A ^a  

^a Giant Food Inc   (United States)

Author keywords

Acne vulgaris; Advertising; Bladder diseases; Comprehension; Depression; Diabetes mellitus; Hypercholesterolemia; Labeling; Mechanism of action; Migraine; Osteoporosis; Patient information; Prescriptions; Rhinitis

Indexed keywords

ACNE; ALLERGIC RHINITIS; ARTICLE; CONSUMER; DEPRESSION; DIABETES MELLITUS; DRUG INFORMATION; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; HEALTH EDUCATION; HYPERCHOLESTEROLEMIA; MIGRAINE; OSTEOPOROSIS; OVERACTIVE BLADDER; PRESCRIPTION; PRIORITY JOURNAL;

EID: 15044343778     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.6.620     Document Type: Article

References (17)

1. Action plan for the provision of useful prescription medicine information, presented to the honorable Donna E. Shalala, Secretary of the department of Health and Human Services, by the Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information. December 1996. Keystone report no. 63. www. keystone.org/ Public_ Policy/Publications/ publications.html (accessed 2005 Jan 2).
2. Consumer and physician attitudes toward direct-to-consumer advertising. New York: Time, Inc., 1998 Aug: 15.
3. Drazen JM. The consumer and the learned intermediary in health care. N Engl J Med. 2002; 346:523-4. Editorial.
4. Lee AJ, Lee AM. Direct-to-consumer advertising: changing the face of pharmaceutical marketing. Concord, MA: Morpace Pharma Group, Ltd.; 2000 Mar.
5. Bell RA, Wilkes MS, Kravitz RL. The educational value of consumer-targeted prescription drug print advertising. J Fam Pract. 2000; 49:1092-8.
6. Stryer D, Bero LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Intern Med. 1996; 11:575-83.
7. Professional Management Services. Fulfillment: quality is ...? www.promgmsrv. com/articles/fq.html (accessed 2005 Jan 2).
8. Federal Food, Drug, and Cosmetic Act. Sec 201[321](k).
9. Federal Food, Drug, and Cosmetic Act. Sec 201[321](m).
10. 21 C.F.R. Part 202.1(1)(2).
11. Bernier MJ. Developing and evaluating printed education materials: a prescriptive model for quality. Orthop Nurs. 1993; 12:39-46.
12. Glanz K, Rudd J. Readability and content analysis of print cholesterol education materials. Patient Educ Couns. 1990; 16:109-18.
13. Farrell-Miller P, Gentry P. How effective are your patient education materials? Guidelines for developing and evaluating written educational materials. Diabetes Educ. 1989; 15:418-22.
14. 21 C.F.R. Part 202.1(5)(i).
15. Thomas M, Lexchin J. Responsiveness to physicians' requests for information concerning drug interactions: a comparison of brand and generic companies. Soc Sci Med. 1990; 31:153-7.
16. Generali JA, Hogan L. A comparison of pharmaceutical manufacturers as a source of drug information to a telephone inquiry: generic vs brand. Drug Inf J. 1983; 17:195-204.
17. Rohret L, Ferguson KJ. Effective use of patient education illustrations. Patient Educ Couns. 1990; 15:73-5.